Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. Launches Reserve Sleep Gummies

Sep 5, 2023

CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

Aug 14, 2023

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

Aug 1, 2023

CV Sciences to Participate in LD Micro Invitational Conference

Jun 1, 2023

CV Sciences, Inc. Reports First Quarter 2023 Financial Results

May 15, 2023

CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023

May 9, 2023

CV Sciences, Inc. Introduces New THC Offering

Apr 3, 2023

CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results

Mar 29, 2023

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

Mar 24, 2023

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

Mar 23, 2023